Literature DB >> 22407325

Myeloperoxidase production by macrophage and risk of atherosclerosis.

Mahir Karakas1, Wolfgang Koenig.   

Abstract

Myeloperoxidase (MPO), a member of the heme peroxidase superfamily, is a leukocyte-derived enzyme that generates reactive intermediates, leading to oxidative damage of host lipids and proteins. It has been shown that MPO is present within atherosclerotic plaque in human arteries and contributes to atherogenesis by catalyzing oxidative reactions in the vascular wall. This review provides an overview of the analytical and pathophysiologic characteristics of MPO and summarizes the possible clinical applicability of MPO as a marker for diagnosis of acute coronary syndrome and a marker for prediction of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407325     DOI: 10.1007/s11883-012-0242-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  49 in total

1.  Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males.

Authors:  Lawrence W Castellani; James J Chang; Xuping Wang; Aldons J Lusis; Wanda F Reynolds
Journal:  J Lipid Res       Date:  2006-04-25       Impact factor: 5.922

2.  Statins promote potent systemic antioxidant effects through specific inflammatory pathways.

Authors:  Mehdi H Shishehbor; Marie-Luise Brennan; Ronnier J Aviles; Xiaoming Fu; Marc S Penn; Dennis L Sprecher; Stanley L Hazen
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

3.  Myeloperoxidase binds to low-density lipoprotein: potential implications for atherosclerosis.

Authors:  A C Carr; M C Myzak; R Stocker; M R McCall; B Frei
Journal:  FEBS Lett       Date:  2000-12-29       Impact factor: 4.124

4.  Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites.

Authors:  S J Weiss; S Regiani
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

5.  Hydrogen peroxide production during experimental protein glycation.

Authors:  Z Y Jiang; A C Woollard; S P Wolff
Journal:  FEBS Lett       Date:  1990-07-30       Impact factor: 4.124

6.  Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events.

Authors:  Nathan D Wong; Heidi Gransar; Jagat Narula; Leslee Shaw; Johanna H Moon; Romalisa Miranda-Peats; Alan Rozanski; Sean W Hayes; Louise E J Thomson; John D Friedman; Daniel S Berman
Journal:  JACC Cardiovasc Imaging       Date:  2009-09

7.  Usefulness of myeloperoxidase levels in healthy elderly subjects to predict risk of developing heart failure.

Authors:  W H Wilson Tang; Ronit Katz; Marie-Luise Brennan; Ronnier J Aviles; Russell P Tracy; Bruce M Psaty; Stanley L Hazen
Journal:  Am J Cardiol       Date:  2009-03-13       Impact factor: 2.778

8.  Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women.

Authors:  Jamal S Rana; Benoit J Arsenault; Jean-Pierre Després; Mélanie Côté; Philippa J Talmud; Ewa Ninio; J Wouter Jukema; Nicholas J Wareham; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  Eur Heart J       Date:  2009-02-18       Impact factor: 29.983

9.  The effects of high molecular weight- and low molecular weight-heparins on superoxide ion production and degranulation by human polymorphonuclear leukocytes.

Authors:  C Léculier; N Couprie; P Adeleine; P Leitienne; A Francina; M Richard
Journal:  Thromb Res       Date:  1993-03-15       Impact factor: 3.944

10.  Myeloperoxidase, a leukocyte-derived vascular NO oxidase.

Authors:  Jason P Eiserich; Stephan Baldus; Marie-Luise Brennan; Wenxin Ma; Chunxiang Zhang; Albert Tousson; Laura Castro; Aldons J Lusis; William M Nauseef; C Roger White; Bruce A Freeman
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

View more
  18 in total

1.  Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous Administration.

Authors:  Diana Amantea; Michelangelo Certo; Francesco Petrelli; Giacinto Bagetta
Journal:  Assay Drug Dev Technol       Date:  2016-07-08       Impact factor: 1.738

2.  The sexual dimorphism associated with pulmonary hypertension corresponds to a fibrotic phenotype.

Authors:  Olga Rafikova; Ruslan Rafikov; Mary Louise Meadows; Archana Kangath; Danny Jonigk; Stephen M Black
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

3.  Lifestyle predictors of oxidant and antioxidant enzyme activities and total antioxidant capacity in healthy women: a cross-sectional study.

Authors:  Amjad A Mahasneh; Yali Zhang; Hua Zhao; Christine B Ambrosone; Chi-Chen Hong
Journal:  J Physiol Biochem       Date:  2016-09-07       Impact factor: 4.158

Review 4.  Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.

Authors:  Kye S Kim; Chul Gyu Song; Peter M Kang
Journal:  Antioxid Redox Signal       Date:  2018-01-30       Impact factor: 8.401

5.  Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.

Authors:  Alexander P Reiner; Jaana Hartiala; Tanja Zeller; Joshua C Bis; Josée Dupuis; Myriam Fornage; Jens Baumert; Marcus E Kleber; Philipp S Wild; Stephan Baldus; Suzette J Bielinski; João D Fontes; Thomas Illig; Brendan J Keating; Leslie A Lange; Francisco Ojeda; Martina Müller-Nurasyid; Thomas F Munzel; Bruce M Psaty; Kenneth Rice; Jerome I Rotter; Renate B Schnabel; W H Wilson Tang; Barbara Thorand; Jeanette Erdmann; David R Jacobs; James G Wilson; Wolfgang Koenig; Russell P Tracy; Stefan Blankenberg; Winfried März; Myron D Gross; Emelia J Benjamin; Stanley L Hazen; Hooman Allayee
Journal:  Hum Mol Genet       Date:  2013-04-24       Impact factor: 6.150

Review 6.  Biomarkers of plaque instability.

Authors:  P K Shah
Journal:  Curr Cardiol Rep       Date:  2014-12       Impact factor: 2.931

7.  MPO Promoter Polymorphism rs2333227 Enhances Malignant Phenotypes of Colorectal Cancer by Altering the Binding Affinity of AP-2α.

Authors:  Qingtao Meng; Shenshen Wu; Yajie Wang; Jin Xu; Hao Sun; Runze Lu; Na Gao; Hongbao Yang; Xiaobo Li; Boping Tang; Michael Aschner; Rui Chen
Journal:  Cancer Res       Date:  2018-03-14       Impact factor: 12.701

8.  Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus.

Authors:  Carolyne K Smith; Anuradha Vivekanandan-Giri; Chongren Tang; Jason S Knight; Anna Mathew; Robin L Padilla; Brenda W Gillespie; Carmelo Carmona-Rivera; Xiaodan Liu; Venkataraman Subramanian; Sarfaraz Hasni; Paul R Thompson; Jay W Heinecke; Rajiv Saran; Subramaniam Pennathur; Mariana J Kaplan
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

9.  Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis.

Authors:  Jia Yang; Xing-Xing Liu; Heng Fan; Qing Tang; Zhe-Xing Shou; Dong-Mei Zuo; Zhou Zou; Meng Xu; Qian-Yun Chen; Ying Peng; Shuang-Jiao Deng; Yu-Jin Liu
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

10.  Association of Plasma Myeloperoxidase Level with Risk of Coronary Artery Disease in Patients with Type 2 Diabetes.

Authors:  Ping Song; Jin Xu; Yongfeng Song; Shiliang Jiang; Haitao Yuan; Xu Zhang
Journal:  Dis Markers       Date:  2015-09-16       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.